INTRAVITREAL BEVACIZUMAB FOR THE TREATMENT OF CHOROIDAL HEMANGIOMAS

Authors

Institutions

Publication Details

Journal
Retina
Published
2024-12-12
DOI
https://doi.org/10.1097/iae.0000000000004323
Citations
1
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.54
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

INTRAVITREAL BEVACIZUMAB FOR THE TREATMENT OF CHOROIDAL HEMANGIOMAS

Guy S. Negretti, Hassan E. Elkayal, Mandeep S. Sagoo
1 citations
Retina
Ocular Oncology and Treatments
0.54
article

INTRAVITREAL BEVACIZUMAB FOR THE TREATMENT OF CHOROIDAL HEMANGIOMAS

Guy S. Negretti, Hassan E. Elkayal, Mandeep S. Sagoo
article en
1 citations

Abstract

No abstract available for this paper.
RetinaVol. 45(3)
Moorfields Eye Hospital (GB), University College London (GB), Alexandria University (EG)
Good health and well-being
Openalex Percentile: Top 29%
Ocular Oncology and Treatments
0.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

INTRAVITREAL BEVACIZUMAB FOR THE TREATMENT OF CHOROIDAL HEMANGIOMAS — Guy S. Negretti, Hassan E. Elkayal, et al. · Retina (2024) | TGRS Research Map | TGRS